Krystal G, Eaves C J, Eaves A C
Br J Haematol. 1984 Nov;58(3):533-46. doi: 10.1111/j.1365-2141.1984.tb04001.x.
A method for both concentrating and purifying human urinary erythropoietin (Ep) using CM Affi-Gel Blue is described. We have found that up to 40 litres of urine can be processed on a 1 litre gel bed of this material. This gives a 25-50-fold purification of Ep with an apparent Ep recovery in excess of 100%. The high recovery of Ep is probably due, in part, to the removal of inhibitors present in the initial urine. By selecting urine that contains high levels of Ep (greater than 0.5 units/ml), it is possible with this method routinely to obtain preparations with specific activities of 100-300 units of Ep per mg protein. Such preparations are noninhibitory when assayed in either short-term suspension cultures or in longer-term methylcellulose cultures at concentrations up to 5-10 units/ml. Similar tests with these same bioassay systems have shown that other non-Ep stimulating factors (i.e. erythroblast enhancing factor (EEF), granulocyte/macrophage colony stimulating factor (GM-CSF) and burst promoting activity (BPA) ) are also not present at detectable levels. In this study we also show that the loss of biological activity which often occurs when partially purified Ep preparations are stored in solution is markedly reduced in the presence of either 1% bovine serum albumin or 0.1% sodium dodecyl sulphate.
描述了一种使用CM亲和凝胶蓝浓缩和纯化人尿促红细胞生成素(Ep)的方法。我们发现,在1升这种材料的凝胶床上可处理多达40升尿液。这可使Ep得到25至50倍的纯化,表观Ep回收率超过100%。Ep的高回收率可能部分归因于去除了初始尿液中存在的抑制剂。通过选择含有高水平Ep(大于0.5单位/毫升)的尿液,用这种方法通常可以获得每毫克蛋白质具有100至300单位Ep比活性的制剂。在短期悬浮培养或长期甲基纤维素培养中,浓度高达5至10单位/毫升时进行测定,此类制剂无抑制作用。用这些相同的生物测定系统进行的类似试验表明,其他非Ep刺激因子(即成红细胞增强因子(EEF)、粒细胞/巨噬细胞集落刺激因子(GM-CSF)和爆式促进活性(BPA))也未达到可检测水平。在本研究中,我们还表明,当部分纯化的Ep制剂在溶液中储存时经常发生的生物活性丧失,在存在1%牛血清白蛋白或0.1%十二烷基硫酸钠的情况下会显著降低。